PureTech Health plc
PTCHFNext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for PTCHF. That does not mean none is planned.
Get an email about PTCHF's next catalysts
Track PureTech Health (PTCHF) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
0 upcoming, 0 past
No catalysts found.
Market Overview
Stock performance and key metrics
Deupirfenidone
Idiopathic Pulmonary Fibrosis (IPF)
Pirfenidone
Idiopathic Pulmonary Fibrosis
LYT-300
Healthy Volunteers
LYT-200
Metastatic Cancer
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Deupirfenidone | Phase 3 | Idiopathic Pulmonary Fibrosis (IPF) | - | - |
Pirfenidone | Phase 2 | Idiopathic Pulmonary Fibrosis | - | - |
LYT-300 | Phase 2 | Healthy Volunteers | - | - |
LYT-200 | Phase 2 | Metastatic Cancer | - | - |
Frequently asked questions
What is in PureTech Health plc's drug pipeline?β
CatalystAlert tracks 4 drug candidates in PureTech Health plc's (PTCHF) pipeline across Phase 3, Phase 2. Its lead program is Deupirfenidone (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is PureTech Health plc's next FDA catalyst?β
CatalystAlert tracks every upcoming catalyst for PureTech Health plc (PTCHF) β PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings β each confidence-rated as confirmed, estimated or AI-detected.
How do I track PTCHF biotech catalysts?β
Add PTCHF to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow PureTech Health plc's live catalyst calendar, drug pipeline and clinical-trial timeline on this page β sourced from ClinicalTrials.gov, FDA and SEC filings.
